Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia. — CFSMEATLAS
Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia.
Davis, Leah, Higgs, Maisy, Snaith, Ailsa et al. · Frontiers in neuroscience · 2025 · DOI
Quick Summary
This review examined research showing that ME/CFS, Gulf War Syndrome, and fibromyalgia may share similar problems with how the body produces energy and handles stress at the cellular level. Scientists found that these three conditions show signs of disrupted fat metabolism, energy production difficulties, and increased cellular damage from oxidative stress. Better understanding these shared biological problems could help doctors diagnose these conditions faster and develop treatments that target the root causes rather than just treating symptoms.
Why It Matters
Identifying shared metabolic abnormalities across ME/CFS and related conditions could accelerate development of disease-specific biomarkers for earlier, more accurate diagnosis—addressing a major clinical gap where patients currently face lengthy, costly diagnostic processes. Understanding common metabolic mechanisms opens pathways for targeted treatments addressing underlying disease biology rather than symptomatic management alone, potentially transforming care for millions of patients with these debilitating conditions.
Observed Findings
ME/CFS, GWS, and FM all demonstrate dysregulation in lipid metabolism pathways
Elevated oxidative stress markers are consistently reported across all three conditions
Energy production and mitochondrial function abnormalities are documented in these illnesses
Altered metabolite levels in key biochemical pathways suggest common metabolic phenotypes
Current diagnostic approaches lack reliable biomarkers, requiring lengthy exclusionary testing
Inferred Conclusions
ME/CFS, GWS, and FM share common biochemical abnormalities involving metabolic dysregulation and oxidative stress despite different clinical presentations
Elevated oxidative stress may be a central mechanism contributing to symptoms across these conditions and represents a potential therapeutic target
Metabolomic and proteomic profiling could identify both disease-specific and shared biomarkers to improve diagnostic accuracy and drive development of targeted treatments
Standardized, comprehensive analyses using modern metabolomic and proteomic technologies are essential for elucidating disease mechanisms and advancing precision medicine approaches
Remaining Questions
What are the precise molecular mechanisms linking metabolic dysregulation to post-exertional malaise and other core symptoms?
What This Study Does Not Prove
This systematic review does not establish causation—it identifies correlations between metabolic alterations and disease symptoms without proving which abnormalities drive disease development versus result from illness. The review does not validate any single biomarker for clinical diagnostic use; it synthesizes existing evidence and identifies patterns requiring prospective validation studies. It also does not demonstrate whether correcting these metabolic abnormalities would improve patient outcomes.